Shehnaaz Suliman

Insider Reports History

Entity
Individual
Location
901 Gateway Blvd, South San Francisco, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shehnaaz Suliman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Ultragenyx Pharmaceutical Inc. Director Common Stock 20.2K $909K $45.00 Jun 18, 2024 Direct
Alector, Inc. President and COO Common Stock 103K $570K $5.56 Dec 13, 2021 Direct
10x Genomics, Inc. Director Class A Common Stock 13.3K $322K $24.30 Jun 11, 2024 Direct
Alector, Inc. President and COO Employee Stock Option (right to buy) 305K Dec 13, 2021 Direct
Ultragenyx Pharmaceutical Inc. Director Stock Option (Right to Buy) 9.9K Jun 18, 2024 Direct
10x Genomics, Inc. Director Stock Option (right to buy) 4.66K Jun 14, 2023 Direct

Insider Reports Filed by Shehnaaz Suliman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Jun 18, 2024 2 $0 4 Jun 20, 2024 Director
TXG 10x Genomics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
TXG 10x Genomics, Inc. Jun 14, 2023 2 $0 4 Jun 16, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 7, 2023 2 $0 4 Jun 9, 2023 Director
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2022 2 $0 4 Jun 28, 2022 Director
TXG 10x Genomics, Inc. Jun 15, 2022 2 $0 4 Jun 17, 2022 Director
ALEC Alector, Inc. Dec 10, 2021 8 -$641K 4 Dec 14, 2021 President and COO
ALEC Alector, Inc. Dec 8, 2021 10 -$1.22M 4 Dec 10, 2021 President and COO
RARE Ultragenyx Pharmaceutical Inc. Jun 24, 2021 2 $0 4 Jun 28, 2021 Director
TXG 10x Genomics, Inc. Jun 11, 2021 2 $0 4 Jun 15, 2021 Director
ALEC Alector, Inc. May 7, 2021 1 $0 4 May 11, 2021 President and COO